Ceeto Capital Group’s VivoSim Labs VIVS Stock Holding History

Ceeto Capital Group’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-375	Closed	-$200K	–	130
2017 Q3	$200K	Buy	+375	New	+$200K	0.15%	117

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ceeto Capital Group's VIVS Position: Q4 2017 in Review

Ceeto Capital Group sold out of VivoSim Labs (VIVS) in Q4 2017, closing a stake of 375 shares — an estimated $200K sold.

Ceeto Capital Group first reported a position in VIVS in Q3 2017 and held it in 1 quarter. The position peaked at $200K in Q3 2017. 123 funds tracked by Wall St. Rank hold VIVS as of Q4 2017.

Ceeto Capital Group reported no remaining VivoSim Labs position as of Q4 2017 after selling out during the quarter.
Ceeto Capital Group sold 375 VivoSim Labs shares in Q4 2017, an estimated $200K.
Ceeto Capital Group first reported a position in VivoSim Labs in Q3 2017 and held it in 1 quarter.
Ceeto Capital Group's VivoSim Labs position peaked at $200K in Q3 2017.
123 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2017.

Based on Ceeto Capital Group's 13F filing for Q4 2017, filed 12 Feb 2018.